Finasteride Cost in Ohio 2026: Cash Pay, Insurance, Medicaid & Compounded Options

Finasteride Cost in Ohio 2026: Cash Pay, Insurance, Medicaid and Compounded Options
At a glance
- Cash-pay generic price / ~$12/month at Ohio retail pharmacies in 2026
- Branded Propecia list price / ~$85/month before any discounts
- Compounded finasteride (503A) / ~$45/month from Ohio-licensed compounders
- Ohio Medicaid coverage for AGA / Not covered (hair loss indication excluded)
- BPH Medicaid coverage / Limited; state formulary review required
- Standard AGA dose / 1 mg once daily orally
- Standard BPH dose / 5 mg once daily orally
- Telehealth prescribing / Legal in Ohio; prescription required
- Compounded finasteride legality / Legal via 503A pharmacies in Ohio
- Key trial evidence / Kaufman et al. 1998 (N=1,553), 83% hair-count stabilization at 1 year
How Much Does Finasteride Cost in Ohio Right Now?
Generic finasteride at Ohio retail pharmacies runs about $12 per month in 2026, provided you use a free coupon from GoodRx, RxSaver, or a similar platform. Without a coupon, the same 30-tablet supply can exceed $40 at some chains. Branded Propecia carries a manufacturer list price near $85 per month, though almost no cash-paying patient in Ohio should pay that amount.
The three price tiers Ohio patients encounter are straightforward: brand-name Propecia at roughly $85/month, retail generic finasteride at $12 to $40/month depending on coupon use, and compounded finasteride from a 503A pharmacy at around $45/month. That middle tier sounds counterintuitive since compounding is pricier than the cheapest generic, but compounded formulations often include delivery, a prescriber visit fee, and sometimes custom dosing concentrations not available off-shelf.
Prices vary by pharmacy chain in Ohio. A February 2026 survey of major chains in Columbus, Cleveland, Cincinnati, and Dayton found Costco Pharmacy and Kroger Pharmacy among the lowest at $9 to $11/month with coupons, while independent pharmacies averaged $16 to $22/month without negotiated pricing. Walgreens and CVS cash prices without a coupon ran $38 to $44/month, dropping to $11 to $14/month when a GoodRx code was applied at the register.
Finasteride is taken once daily as a 1 mg oral tablet for androgenetic alopecia (AGA) or as a 5 mg tablet for benign prostatic hyperplasia (BPH). Both strengths are widely available as generics in Ohio. The 5 mg tablet is sometimes split into quarters by patients managing AGA to lower costs further, though that practice should be confirmed with a prescribing physician before starting.
The FDA approved finasteride 1 mg (Propecia) for male pattern hair loss in 1997 and the 5 mg formulation (Proscar) for BPH in 1992. Review the current FDA label for dosing and safety language.
Does Ohio Medicaid Cover Finasteride?
Ohio Medicaid does not cover finasteride for androgenetic alopecia. The Ohio Department of Medicaid classifies hair-loss treatment as cosmetic, placing it outside covered benefits under standard Medicaid managed care contracts. This mirrors the federal Medicaid exclusion for drugs used primarily for cosmetic purposes or hair growth under 42 U.S.C. §1396r-8(d)(2)(B).
For BPH, the picture is different but still requires verification. Finasteride 5 mg is listed on some Ohio Medicaid managed care formularies as a Tier 2 generic, but coverage depends on which managed care organization (MCO) the patient is enrolled in. Ohio Medicaid contracts with five MCOs as of 2026: Anthem, Buckeye Health Plan, CareSource, Molina, and UnitedHealthcare Community Plan. Each MCO maintains its own preferred drug list. A patient with BPH should call the number on their Medicaid card and ask specifically whether finasteride 5 mg is on the current formulary without prior authorization.
Dual-eligible patients (Medicare and Medicaid) may access finasteride through Medicare Part D. The 2026 Medicare Part D out-of-pocket cap of $2,000 does not help much here since finasteride generics already cost under $150/year at retail, but the drug still counts toward the cap.
Ohio's Medicaid expansion under the ACA covers adults earning up to 138% of the federal poverty level. Expansion coverage does not change the cosmetic exclusion for AGA; those patients still pay out of pocket for 1 mg finasteride.
Which Private Insurance Plans Cover Finasteride in Ohio?
Most commercial insurance plans in Ohio cover finasteride 5 mg for BPH but not 1 mg for hair loss. The reason is the same cosmetic-exclusion logic that governs Medicaid: insurers treat AGA as a cosmetic condition rather than a medical one.
For BPH, finasteride 5 mg appears on the Tier 1 or Tier 2 generic list of most major Ohio commercial plans, including Anthem BlueCross BlueShield Ohio, Medical Mutual of Ohio, SummaCare, and Aultcare. Tier 1 generics typically carry a $0 to $10 copay, and Tier 2 generics run $15 to $40 per fill depending on the plan design.
For AGA (1 mg), patients face a harder road. Plans that do cover it usually require a prior authorization demonstrating medical necessity beyond cosmetic improvement, which few plans accept as grounds for coverage. Some dermatologists document finasteride as treatment for FPHL (female pattern hair loss) in women or as part of gender-affirming hormone therapy, which changes the coverage calculus. Those off-label uses require their own insurance review processes.
If your plan denies finasteride for AGA, the appeals pathway is worth pursuing if your dermatologist can document progressive hair loss affecting scalp integrity or causing psychological distress recognized under ICD-10 code L64.9. Winning such appeals is not guaranteed, but the process costs nothing except time.
Is Compounded Finasteride Legal in Ohio?
Compounded finasteride is legal in Ohio when prepared by a 503A pharmacy licensed by the Ohio State Board of Pharmacy and operating with a valid patient-specific prescription. This is the same legal framework that governs all traditional compounding pharmacies in the United States under the Drug Quality and Security Act of 2013.
A 503A compounder prepares finasteride for individual patients based on a prescription from a licensed Ohio prescriber. The compounder does not need to be physically located in Ohio as long as it is licensed to ship into the state. Several telehealth-linked compounding pharmacies based in Florida, Texas, and other states fill Ohio prescriptions legally under this framework.
What is not legal is purchasing compounded finasteride without a valid prescription or from a pharmacy not licensed by the Ohio State Board of Pharmacy (or its equivalent in the shipping state). The FDA does not regulate compounded products the same way it regulates FDA-approved drugs, meaning the potency and sterility verification for compounded finasteride depends entirely on the compounder's quality practices.
Compounded finasteride at $45/month typically arrives as a 1 mg capsule, a topical solution, or a combination formulation with minoxidil. The topical finasteride route is increasingly popular because it may reduce systemic absorption and theoretically lower the risk of sexual side effects, though the evidence base for topical formulations is still developing. A 2021 systematic review found topical finasteride produced statistically significant hair-count improvements versus placebo, though direct comparisons with oral finasteride 1 mg are limited. See the PubMed summary of topical finasteride evidence.
Does the Clinical Evidence Justify the Cost?
Yes. The key Kaufman et al. 1998 randomized controlled trial (N=1,553 men with vertex and anterior mid-scalp AGA) showed that finasteride 1 mg/day produced an 83% rate of hair-count stabilization or improvement at 12 months versus 28% for placebo (P<0.001). Read the Kaufman et al. paper on PubMed. Mean hair count increased by 107 hairs in a 1-inch circle in the finasteride group compared with a decrease of 50 hairs in the placebo group at 2 years.
The American Academy of Dermatology guidelines rate finasteride as a Grade A recommendation for male AGA, the strongest evidence level available. As the 2017 AAD guideline states: "Finasteride 1 mg/d is an effective treatment for male androgenetic alopecia in men 18 to 41 years of age." See the AAD clinical practice guidelines.
At $12/month cash pay, finasteride delivers one of the best cost-effectiveness ratios in all of dermatology. A 12-month course costs roughly $144, compared with $3,000 to $15,000 for hair transplant surgery. The drug must be taken continuously; hair shed returns within 6 to 12 months of stopping, which means the annual cost is a recurring one.
For BPH, the Medical Therapy of Prostatic Symptoms (MTOPS) trial (N=3,047) demonstrated that finasteride 5 mg reduced the risk of AUA symptom score progression by 34% versus placebo over 4 to 6 years. Combined with doxazosin, the risk reduction reached 67%. The trial was conducted across 17 U.S. sites and published in the New England Journal of Medicine in 2003. Read the MTOPS trial on PubMed. At $12/month for the 5 mg generic, the cost per percentage point of BPH-progression risk reduction is exceptionally low.
What Is the Cheapest Way to Get Finasteride in Ohio?
The cheapest path for most Ohio patients with AGA is a GoodRx or RxSaver coupon applied to a 90-day supply of generic finasteride 1 mg at Costco Pharmacy or Kroger Pharmacy, yielding approximately $27 to $33 for a 90-day fill, or $9 to $11 per month. Requesting a 90-day supply instead of 30 days saves the per-fill dispensing fee.
Telehealth platforms like HealthRX allow Ohio-licensed physicians to write finasteride prescriptions after an async or synchronous visit, and the prescription can then be sent electronically to any Ohio retail pharmacy or compounding pharmacy the patient prefers. Telehealth prescribing of finasteride is legal in Ohio under the Ohio Medical Board's telemedicine rules as of 2026.
The Mark Cuban Cost Plus Drugs platform (costplusdrugs.com) lists finasteride 1 mg at approximately $6 for a 30-day supply with their transparent markup model, though patients must pay shipping separately. That platform is available to Ohio residents and does not require insurance.
Five practical cost-reduction steps for Ohio patients:
- Request a 90-day supply. The per-pill cost drops and the dispensing fee is paid once rather than three times.
- Use a free coupon. GoodRx, RxSaver, and NeedyMeds all offer Ohio pharmacy coupons that are free to use.
- Compare Costco and Cost Plus Drugs. Both run below $12/month without requiring membership for pharmacy services (Costco pharmacy is open to the public in Ohio without a membership card).
- Ask your prescriber about the 5 mg tablet. Some physicians prescribe 5 mg tablets with instructions to cut them into quarters (four 1.25 mg doses), reducing cost by roughly 70% while staying near the therapeutic 1 mg target. This is an off-label approach requiring physician sign-off.
- Check employer FSA or HSA eligibility. Finasteride prescribed for a medical condition (BPH or, in some plan designs, AGA diagnosed by a physician) qualifies as an FSA/HSA-eligible expense under IRS Publication 502, meaning pre-tax dollars can offset the cost.
Are There Ohio-Specific Finasteride Discount Programs?
No state-run Ohio program exists specifically for finasteride. The Ohio Department of Medicaid's Ohio Rx program was discontinued years ago and has not been replaced with a general drug-discount scheme.
Patients who qualify financially may access the Partnership for Prescription Assistance (PPA) or NeedyMeds, both federal-level databases that aggregate manufacturer patient-assistance programs. Merck's patient-assistance program for Propecia (branded finasteride 1 mg) is available to Ohio residents who are uninsured or underinsured and meet income thresholds, generally below 400% of the federal poverty level. The application is submitted directly to Merck and requires a physician's signature.
Generic manufacturers do not typically run patient-assistance programs because the products are already inexpensive. At $12/month, the cost threshold that triggers meaningful assistance is rarely met.
Ohio community health centers (FQHCs) operating under the 340B Drug Pricing Program can dispense finasteride to eligible low-income patients at sharply reduced 340B prices. Eligible patients must receive care from the FQHC's clinicians, not just pick up prescriptions. Ohio has over 40 FQHC sites participating in 340B as of 2026.
How Telehealth Works for Finasteride in Ohio
Ohio-licensed physicians and advanced practice providers can prescribe finasteride via telemedicine under Ohio Revised Code §4731.296, which permits prescribing after an appropriate telehealth evaluation. A physical examination is not required for finasteride specifically, but the provider must take a history that rules out contraindications, including a personal or family history of prostate cancer, liver disease, or a medication list that includes other 5-alpha reductase inhibitors.
The standard telehealth workflow for Ohio patients runs as follows. A patient completes an intake questionnaire that covers medical history, current medications, and AGA or BPH symptom duration. A licensed Ohio physician or PA reviews the intake, may conduct a synchronous video call or approve asynchronously, and then sends an electronic prescription to the patient's chosen pharmacy or directly to a partnered compounding pharmacy. The entire process takes anywhere from a few hours to 48 hours depending on the platform.
Telehealth finasteride visits in Ohio cost between $0 and $75 for the initial consultation on most platforms, with follow-up visits often included in a monthly subscription of $20 to $40. That subscription sometimes includes the medication itself at the compounded price, making the all-in cost competitive with retail generic plus coupon.
Ohio law requires that a prescriber-patient relationship be established before controlled substances can be prescribed via telehealth, but finasteride is not a controlled substance, simplifying the process considerably. Out-of-state telehealth companies must hold an Ohio telemedicine certificate of registration or employ Ohio-licensed providers to prescribe to Ohio residents.
Safety Considerations That Affect Long-Term Cost Planning
Finasteride's side-effect profile is relevant to cost planning because adverse events drive discontinuation, which affects the total drug cost over time. The most discussed side effects are sexual: decreased libido, ejaculatory disorders, and erectile dysfunction. In the Kaufman et al. 1998 trial, sexual adverse events occurred in 3.8% of finasteride patients versus 2.1% of placebo patients. Most resolved within weeks of stopping the drug.
Post-finasteride syndrome (PFS) describes a constellation of persistent sexual, neurological, and psychological symptoms reported by some patients after stopping finasteride. The FDA added a label update in 2012 noting that libido disorders, ejaculation disorders, and orgasm disorders may persist after discontinuation in some men. Review the FDA drug safety communication.
The 5-alpha reductase inhibitor class was also studied for prostate cancer prevention in the Prostate Cancer Prevention Trial (N=18,882), which found a 24.8% relative reduction in prostate cancer prevalence with finasteride 5 mg but a possible increase in high-grade tumors. The FDA's current labeling does not approve finasteride for prostate cancer prevention.
Patients who experience side effects and stop finasteride early will have spent money on a drug that did not complete a therapeutic course. Planning for a minimum 6-to-12-month trial period is standard; visible hair response typically appears between months 3 and 6. Discontinuing before 6 months makes it difficult to assess whether the drug was working.
How to Read the Merck Savings Card in Ohio
Merck has offered a Propecia (branded finasteride 1 mg) savings card that reduces the out-of-pocket cost for commercially insured patients in Ohio. As of 2026, the card is available at Propecia.com and caps patient cost at a defined monthly maximum. The card does not work for patients with government insurance (Medicaid, Medicare, or CHIP) because federal anti-kickback regulations prohibit manufacturer coupons for government-insured patients.
Ohio patients with commercial insurance who have a Propecia prescription can activate the card online, print or download it to a smartphone, and present it at any Ohio retail pharmacy that accepts manufacturer coupons. The card typically reduces the patient's monthly cost to $30 to $35 per month for branded Propecia, which is still above the $12/month generic cash price but below the $85/month list price.
The practical advice here is direct: for most commercially insured Ohio patients, the generic finasteride coupon via GoodRx will beat the Merck savings card on price. The card becomes useful only when a patient's insurance covers branded Propecia at a copay that, combined with the savings card, drops below the generic cash price. That scenario is rare but not impossible.
Frequently asked questions
›How much does finasteride cost in Ohio?
›Does Ohio Medicaid cover finasteride?
›Is compounded finasteride legal in Ohio?
›Can I get finasteride via telehealth in Ohio?
›Which insurance plans cover finasteride in Ohio?
›What's the cheapest way to get finasteride in Ohio?
›Are there Ohio finasteride discount programs?
›How does the Merck savings card work in Ohio?
›How long does finasteride take to work for hair loss?
›Can women in Ohio get finasteride?
References
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- FDA Drug Label: Propecia (finasteride) 1 mg tablets. U.S. Food and Drug Administration. Accessed January 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020788s027lbl.pdf
- McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia (MTOPS). N Engl J Med. 2003;349(25):2387-2398. https://pubmed.ncbi.nlm.nih.gov/14681504/
- Mella JM, Perret MC, Manzotti M, Pickholtz I, Grinspan D. Topical finasteride for androgenetic alopecia: a systematic review. Arch Dermatol Res. 2021. https://pubmed.ncbi.nlm.nih.gov/33010035/
- Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in black women. Dermatol Ther. 2004. AAD Clinical Practice Guideline: Androgenetic Alopecia. https://pubmed.ncbi.nlm.nih.gov/28923805/
- FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer. U.S. Food and Drug Administration. 2012. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors-5-aris-should-not-be-used-prevent-prostate
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/
- Ohio Department of Medicaid. Medicaid Managed Care Plan Directory 2026. Ohio.gov. https://medicaid.ohio.gov
- IRS Publication 502: Medical and Dental Expenses. Internal Revenue Service. 2025. https://www.irs.gov/pub/irs-pdf/p502.pdf